Table 1 Allografts characteristics before transplantation in IP and non-IP donors
Non-steatotic allografts | Steatosic allografts | |||||||
|---|---|---|---|---|---|---|---|---|
Variable | IP ( n =14) group I | Non-IP ( n =14) group II | IP ( n =12) group III | Non-IP ( n =10) group IV | P -value I versus II a | P -value III versus IV a | P -value I versus III a | P -value II versus IV a |
Age of donor (years) | 47.9±13.6 | 50.1±12.1 | 50.5±8.4 | 54.7±10.3 | 0.65 | 0.30 | 0.57 | 0.34 |
Donor hospitalization (days in intensive care unit) | 1.9±1.1 | 1.8±1.0 | 2.1±1.3 | 1.6±0.9 | 0.67 | 0.38 | 0.73 | 0.77 |
Body mass index | 21.7±3.3 | 23.7±2.9 | 25.1±3.7 | 24.9±2.3 | 0.11 | 0.87 | 0.02 | 0.29 |
Histology before reperfusion | ||||||||
Necrosis | ||||||||
Absent | 12/14 | 13/14 | 12/12 | 9/10 | 0.39 | 0.45 | 0.28 | 0.51 |
Mild | 1/14 | 1/14 | 0/12 | 0/10 | 0.52 | — | 0.54 | 0.58 |
Moderate | 1/14 | 0/14 | 0/12 | 1/10 | 0.50 | 0.45 | 0.54 | 0.42 |
Steatosis | ||||||||
Absent | 14/14 | 14/14 | 0/12 | 0/10 | — | — | 10−7 | 5 × 10−7 |
Mild (0–30%) | 0/14 | 0/14 | 8/12 | 8/10 | — | 0.30 | 3 × 10−4 | 6 × 10−5 |
Moderate (30–60%) | 0/14 | 0/14 | 4/12 | 2/10 | — | 0.30 | 0.03 | 0.16 |
High glycogen content (grading ≥2) | 6/14 | 9/14 | 8/12 | 9/10 | 0.16 | 0.19 | 0.15 | 0.15 |
